🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

In our Series on Biomarkers of Neurodegeneration: thelancet.com/series/biomark… Michael Schöll and colleagues discuss challenges in the practical implementation of blood biomarkers (BBs) for Alzheimer’s disease: thelancet.com/journals/lanhl… #openaccess

Excited to have officially joined the #REAL #AD team at Michael Schöll's group this week alongside Laura Stankeviciute, PhD 🙌 and grateful for the great kick-off last week at #CTAD24 where #REAL #ADs first results were presented 🙏⭐️👇 @EndAlz Göteborgs universitet / University of Gothenburg

Very excited to have you onboard! 🎉

🚨 Check out our recent study on Neurology Journal 🧠 Andrei Bieger & colleagues developed an algorithm to compare the outcomes of different Alzheimer’s disease diagnostic criteria in the same group of individuals 🪢👇 neurology.org/doi/10.1212/WN…

Please join us in Gothenburg on January 30 for a symposium on recent advances in the cognitive assessment of neurodegenerative diseases! We are excited to host a truly excellent panel of lecturers! Please register free of charge by email to [email protected] #ENDALZ

Hej hej!🇸🇪 Happy to share that I’ve started a new postdoc with Michael Schöll on the #REAL-AD study! Grateful for joining his incredible team together with Ellen Singleton and contributing to this purposeful research 🧠✨ #endalz

Third time’s a charm! 🎈 Very honoured to be ranked among the world’s most influential researchers according to Clarivate Web of Science three years in a row now! Praise belongs to my team, our collaborators and our study participants! clarivate.com/highly-cited-r…

We're delighted that 22 of our academics have been identified in Clarivate’s annual ‘Highly Cited Researchers List’ 2024, recognising authors of the most influential research papers around the world. 🔗bit.ly/3ZARQ4R

Always my favourite post at the beginning of the year: Registration for our course “Biomarkers for neurodegenerative diseases” is now open! This year’s edition takes place at UCL Queen Square Institute of Neurology in central London on May 12-16. biomarker-course.org

Incredibly happy and proud to share our newest work in Science Translational Medicine showing that Aβ promotes neuronal hyperconnectivity, thereby driving tau spread across connected brain regions. Many thanks to to first authors Sebastian Roemer-Cassiano and Fabian Wagner! science.org/doi/10.1126/sc… Thread below

Ready for the Sahlgrenska Academy Junior Researcher Symposium, hosted by Future Faculty? Join us at 1 PM for an inspiring keynote by Michael Schöll ! 🌟 #Research #FutureFaculty #JuniorResearchers gu.se/en/sahlgrenska…

Congratulations to Will Coath on passing his PhD viva exploring amyloid and tau PET in the Insight 1946 birth cohort! Many thanks to examiners Prof Alexander Hammers and Paresh Malhotra and fellow supervisors Michael Schöll and Jonathan Schott

Why academia is sleepwalking into self-destruction. My editorial Brain If you agree with the sentiments please RT. It's important for all our sakes to stop the madness academic.oup.com/brain/issue/14…

Happy to share our latest work published today in Nature Communications We leverage #ai enhanced microscopy guided #maldi MS_Imaging to delineate #amyloid plaque polymorphism in #Alzheimers Fantastic collaboration with Michael Schöll rdcu.be/ejcHj Sahlgrenska Academy UCL Queen Square Institute of Neurology

So excited and honored to be invited to present the opening plenary at #AIC2025 this year in Toronto! 🧠 🙏 I would be very grateful if you could help me gather the most inspiring papers (including your own!) of the past year by completing this survey: alz.surveymonkey.com/r/923BTQK

'Cautions on utilizing plasma GFAP level as a #biomarker for reactive #astrocytes in #neurodegenerative diseases' Wongu Youn, Mijin Yun C. Justin Lee Michael Schöll Michael Schöll Uni of Gothenburg bit.ly/431DTjH

Tau PET positivity is detectable in a small but nonnegligible proportion of individuals in the preclinical stages of #Alzheimer disease, with increasing frequency in symptomatic stages of the disease. ja.ma/4e29SDX

Our most important paper, out now! A massive international collaboration, led by Alexis Moscoso Rial, featuring over 6500 visually assessed tau PET scans covering the #Alzheimers spectrum! Thank you very much to the numerous contributors and collaborators who made this gem possible.